Canaccord raised the firm’s price target on EverQuote (EVER) to $33 from $30 and keeps a Buy rating on the shares. The firm said Q4 results came in solidly above expectations, with revenue, VMM, and adj. EBITDA all noticeably above estimates as the recovery in auto insurance spending continues. Canaccord said the stock is up but still trades at an attractive valuation, especially in light of ongoing business momentum.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVER:
- EverQuote: Strong Performance and Growth Potential Drive Buy Rating Amid Regulatory Clarity
- EverQuote Reports Strong Financial Growth in 2024
- Closing Bell Movers: Hims & Hers down nearly 20% on earnings miss
- EverQuote sees Q1 revenue $155M-$160M, consensus $136.86M
- EverQuote reports Q4 EPS 33c, consensus 39c